openPR Logo
Press release

Drug Screening Market By 2025 | Comprehensive Study On Roche, Abbott, Quest Diagnostics, Siemens Healthineers, bioMérieux, Thermo Fisher Scientific, LabCorp, Alere Inc. , Express Diagnostics International, Inc.

10-18-2018 03:23 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Drug Screening

Drug Screening

Global drug screening market analyses the current drug industry situations on a large scale to provide the drug screening market developments, market size and progress estimates. The main element details are related to drug screening market’s essential market segments, opportunities and market constraints are presented in this report. Further, this report lists the product definition, applications, market scope, and major product manufacturing regions. An extensive view of the industries’ major manufacturers and supply/demand scenario are covered deeply. This kind of record comprehensively analyses the present drug screening market segments as well as the rising segments which can anticipate the forecast drug screening market’s development in the coming years.

The Global drug screening market accounted to USD XX.XX million in 2017 growing at a CAGR of XX.XX% during the forecast period of 2018 to 2025. Global drug screening market report contains data for historic years 2016, the base year of calculation is 2017 and the Aptamers forecast period is 2018 to 2025.

Get Sample Analysis of This Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market


Forecasting Analysis On Global Drug Screening Market By Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat) and Geography. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance , ketamine, phenethylamines, and piperazine are rising in the drug market.

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance , ketamine, phenethylamines, and piperazine are rising in the drug market. Some of the major players operating in global drug screening market are

· Siemens Healthcare GmbH (Germany)

· Quest Diagnostics Incorporated (U.S.)

· Alere (U.S.)

· Thermo Fisher Scientific, Inc. (U.S.)

· Laboratory Corporation of America Holdings (U.S.)

· Abbott (U.S.)

· Hoffmann -La Roche Ltd(Switzerland)

· BioMerieux SA (France)

· Express Diagnostics Int’l, Inc. (U.S.)

· Drägerwerk AG & Co. KGaA (Germany)

Others: Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S),and Shimadzu Corporation (Japan) among others. The global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global drug screening market shares for global, Europe, North America, Asia Pacific and South America.


Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-screening-market


Global Drug Screening Market Segmentation:
· On the basis of products and services, global drug screening market is segmented into

o Immunoassay Analyzers,

o Chromatography,

o Breath Analyzers,

o Rapid Testing Devices,

o Assay Kits And Reagents.

· On the basis of sample type, global drug screening market is segmented into

o Urine

o Breath

o Saliva

o Hair

o Blood

o Skin

o Sweat

· Due to the low cost and reliability urine sample is the most commonly found sample.

· On the basis of geography, global drug screening market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific, and Middle East & Africa.

· Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

· North America is expected to dominate the market.


Major market drivers and restraints:
• Rising awareness on drug screening policy
• Increasing misuse and consumption of drugs and alcohol
• Addition of drug addicts
• Increasing disposable income
• Growing trend of today’s generation
• Violation of rights related to drug testing in some regions

Key benefits of buying the Report:


This report will enable both of the sides in drug screening market be an established firm or a relative new entrant. It helps the established firms to know about the moves which are being performed by their competitors and also helps the new entrants by educating them about the market situations and the industry trends.

Drug screening report is quite fruitful in helping to understand the market definition and all the aspects of the market including the CAGR value and key profiles.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-screening-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Screening Market By 2025 | Comprehensive Study On Roche, Abbott, Quest Diagnostics, Siemens Healthineers, bioMérieux, Thermo Fisher Scientific, LabCorp, Alere Inc. , Express Diagnostics International, Inc. here

News-ID: 1313420 • Views: 175

More Releases from Data Bridge Market Research

Luxury Folding Carton Market 2019 Top Players are | Smurfit Kappa, DS Smith, Don …
Global Luxury Folding Carton Market is expected to rise to an estimated value of USD 2.85 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increased demand for marketable packaging products from the various end-users along with better shelf-appeal of the product which results in larger customer engagement. Get Sample Analysis of This Market Information at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-luxury-folding-carton-market
Rice Protein Based Infant Formula Market 2019 with Top Competitors Nucitec SA de …
Global Rice Protein Based Infant Formula Market is projected to register a substantial CAGR of 5.9% in the forecast period of 2019 to 2026. Infant formula refers to the food products that are used by the infants during their first months of life providing nutritional requirements until the introduction of appropriate complementary feeding. These infant formulas were available only through physicians when it first appeared during the late 1800s. In 1950s,
Automatic Emergency Braking Market Future Projections and competitive Landscape …
Global Automatic Emergency Braking Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of automatic emergency braking market for global, Europe, North America, Asia-Pacific and South America. Global Automatic Emergency Braking Market Major Competitors Autoliv Inc., Robert Bosch GmbH, Continental AG, Delphi Technologies,
Inflation Device Market Booming Demand for Growing Ageing Population at Highest …
Inflation Device Market report proves to be a perfect solution for pounding profound into essential aspects and elements which empowers the readers to settle on profitable decisions. The report is a profitable wellspring of direction and heading for organizations and people intrigued by the business. This market report makes some significant proposition for new product or service launch in Medical Devices industry before assessing its feasibility. The guideline objective of

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning